212 related articles for article (PubMed ID: 21522157)
1. Enhancement effect of N-methyl-N″-dodecylguanidine on the vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans.
Yutani M; Ogita A; Usuki Y; Fujita K; Tanaka T
J Antibiot (Tokyo); 2011 Jul; 64(7):469-74. PubMed ID: 21522157
[TBL] [Abstract][Full Text] [Related]
2. The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin.
Borjihan H; Ogita A; Fujita K; Hirasawa E; Tanaka T
J Antibiot (Tokyo); 2009 Dec; 62(12):691-7. PubMed ID: 19876074
[TBL] [Abstract][Full Text] [Related]
3. Synergistic fungicidal activities of amphotericin B and N-methyl-N"-dodecylguanidine: a constituent of polyol macrolide antibiotic niphimycin.
Ogita A; Matsumoto K; Fujita K; Usuki Y; Hatanaka Y; Tanaka T
J Antibiot (Tokyo); 2007 Jan; 60(1):27-35. PubMed ID: 17390586
[TBL] [Abstract][Full Text] [Related]
4. Dependence of vacuole disruption and independence of potassium ion efflux in fungicidal activity induced by combination of amphotericin B and allicin against Saccharomyces cerevisiae.
Ogita A; Yutani M; Fujita K; Tanaka T
J Antibiot (Tokyo); 2010 Dec; 63(12):689-92. PubMed ID: 20940723
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system.
Ogita A; Fujita K; Taniguchi M; Tanaka T
Planta Med; 2006 Oct; 72(13):1247-50. PubMed ID: 16902870
[TBL] [Abstract][Full Text] [Related]
6. Visualization analysis of the vacuole-targeting fungicidal activity of amphotericin B against the parent strain and an ergosterol-less mutant of Saccharomyces cerevisiae.
Kang CK; Yamada K; Usuki Y; Ogita A; Fujita KI; Tanaka T
Microbiology (Reading); 2013 May; 159(Pt 5):939-947. PubMed ID: 23475946
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the fungicidal activity of amphotericin B by allicin: effects on intracellular ergosterol trafficking.
Ogita A; Fujita K; Tanaka T
Planta Med; 2009 Feb; 75(3):222-6. PubMed ID: 19053016
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the fungicidal activity of amphotericin B via vacuole disruption by benzyl isothiocyanate, a cruciferous plant constituent.
Yamada N; Murata W; Yamaguchi Y; Fujita KI; Ogita A; Tanaka T
Lett Appl Microbiol; 2021 Apr; 72(4):390-398. PubMed ID: 33128810
[TBL] [Abstract][Full Text] [Related]
9. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans.
An M; Shen H; Cao Y; Zhang J; Cai Y; Wang R; Jiang Y
Int J Antimicrob Agents; 2009 Mar; 33(3):258-63. PubMed ID: 19095412
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro studies on liposomal formulations of amphotericin B and its derivative, N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
Cybulska B; Kupczyk K; Szlinder-Richert J; Borowski E
Acta Biochim Pol; 2002; 49(1):67-75. PubMed ID: 12136958
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship studies on niphimycin, a guanidylpolyol macrolide antibiotic. Part 1: The role of the N-methyl-N''-alkylguanidinium moiety.
Usuki Y; Matsumoto K; Inoue T; Yoshioka K; Iio H; Tanaka T
Bioorg Med Chem Lett; 2006 Mar; 16(6):1553-6. PubMed ID: 16403624
[TBL] [Abstract][Full Text] [Related]
12. Targeted yeast vacuole disruption by polyene antibiotics with a macrocyclic lactone ring.
Ogita A; Fujita K; Usuki Y; Tanaka T
Int J Antimicrob Agents; 2010 Jan; 35(1):89-92. PubMed ID: 19910165
[TBL] [Abstract][Full Text] [Related]
13. Enhancing effects on vacuole-targeting fungicidal activity of amphotericin B.
Ogita A; Fujita K; Tanaka T
Front Microbiol; 2012; 3():100. PubMed ID: 22457662
[TBL] [Abstract][Full Text] [Related]
14. Lysine enhances the effect of amphotericin B against Candida albicans in vitro.
Zhao L; Jiang J; Zhu Z; Liao Z; Yao X; Yang Y; Cao Y; Jiang Y
Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):182-93. PubMed ID: 26711896
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
16. Release of amphotericin B from delivery systems and its action against fungal and mammalian cells.
Legrand P; Chéron M; Leroy L; Bolard J
J Drug Target; 1997; 4(5):311-9. PubMed ID: 9169988
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on cell stimulatory, permeabilizing and toxic effects induced in sensitive and multidrug resistant fungal strains by amphotericin B (AMB) and N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).
Szlinder-Richert J; Cybulska B; Grzybowska J; Borowski E; Prasad R
Acta Biochim Pol; 2000; 47(1):133-40. PubMed ID: 10961686
[TBL] [Abstract][Full Text] [Related]
18. ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans.
Guirao-Abad JP; Sánchez-Fresneda R; Alburquerque B; Hernández JA; Argüelles JC
Int J Med Microbiol; 2017 Jun; 307(4-5):241-248. PubMed ID: 28412040
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence studies on the molecular action of amphotericin B on susceptible and resistant fungal cells.
Haynes MP; Chong PL; Buckley HR; Pieringer RA
Biochemistry; 1996 Jun; 35(24):7983-92. PubMed ID: 8672502
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans.
Chudzik B; Tracz IB; Czernel G; Fiołka MJ; Borsuk G; Gagoś M
Eur J Pharm Sci; 2013 Aug; 49(5):850-7. PubMed ID: 23791641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
